ES557112A0 - Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide - Google Patents

Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide

Info

Publication number
ES557112A0
ES557112A0 ES557112A ES557112A ES557112A0 ES 557112 A0 ES557112 A0 ES 557112A0 ES 557112 A ES557112 A ES 557112A ES 557112 A ES557112 A ES 557112A ES 557112 A0 ES557112 A0 ES 557112A0
Authority
ES
Spain
Prior art keywords
epoxiesteroid
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557112A
Other languages
English (en)
Other versions
ES8707737A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES557112A0 publication Critical patent/ES557112A0/es
Publication of ES8707737A1 publication Critical patent/ES8707737A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES557112A 1984-06-21 1986-10-01 Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide Expired ES8707737A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH300984 1984-06-21
CH464684 1984-09-28

Publications (2)

Publication Number Publication Date
ES557112A0 true ES557112A0 (es) 1987-08-16
ES8707737A1 ES8707737A1 (es) 1987-08-16

Family

ID=25691934

Family Applications (2)

Application Number Title Priority Date Filing Date
ES544387A Expired ES8704967A1 (es) 1984-06-21 1985-06-20 Procedimiento para la obtencion de un 9alfa, 11alfa-epoxiesteroide.
ES557112A Expired ES8707737A1 (es) 1984-06-21 1986-10-01 Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES544387A Expired ES8704967A1 (es) 1984-06-21 1985-06-20 Procedimiento para la obtencion de un 9alfa, 11alfa-epoxiesteroide.

Country Status (16)

Country Link
US (1) US4670551A (es)
EP (1) EP0165902B1 (es)
AR (2) AR242036A1 (es)
AU (1) AU582754B2 (es)
CA (1) CA1239388A (es)
DE (1) DE3569540D1 (es)
DK (1) DK173854B1 (es)
ES (2) ES8704967A1 (es)
FI (1) FI83225C (es)
GR (1) GR851499B (es)
HU (1) HU192232B (es)
IE (1) IE58050B1 (es)
IL (1) IL75569A (es)
NO (1) NO165496C (es)
NZ (1) NZ212492A (es)
PT (1) PT80663B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981744A (en) * 1995-12-11 1999-11-09 G. D. Searle And Co. Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
PT944644E (pt) * 1996-12-11 2003-02-28 Searle & Co Processos para a preparacao de esteroides 9,11-epoxi e intermediarios uteis para esse efeito
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
EP1148061B1 (en) * 1996-12-11 2007-10-17 G.D. Searle LLC. Epoxidation process
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
CA2469616A1 (en) 2001-12-12 2003-06-19 James W. Aiken Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013012A (en) * 1960-12-22 1961-12-12 Searle & Co Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1041534A (en) * 1963-04-24 1966-09-07 Merck & Co Inc 20-spiroxane compounds
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
FI77669C (fi) * 1983-04-13 1989-04-10 Ciba Geigy Ag 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
EP0134529B1 (de) * 1983-08-17 1990-03-21 Schering Aktiengesellschaft 7-alpha-Substituierte 3-Oxo-17alpha-pregn-4-en-21.17-carbolactone, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
CA1239388A (en) 1988-07-19
DK280085A (da) 1985-12-22
AR245731A1 (es) 1994-02-28
PT80663B (en) 1987-05-08
NO165496B (no) 1990-11-12
FI852430L (fi) 1985-12-22
NZ212492A (en) 1989-02-24
FI852430A0 (fi) 1985-06-19
EP0165902A2 (de) 1985-12-27
AU582754B2 (en) 1989-04-13
IE58050B1 (en) 1993-06-16
EP0165902A3 (en) 1986-10-22
ES544387A0 (es) 1987-04-16
DK173854B1 (da) 2001-12-27
FI83225B (fi) 1991-02-28
DE3569540D1 (en) 1989-05-24
US4670551A (en) 1987-06-02
GR851499B (es) 1985-11-25
ES8707737A1 (es) 1987-08-16
NO852501L (no) 1985-12-23
IE851535L (en) 1985-12-21
HUT38367A (en) 1986-05-28
AU4397185A (en) 1986-01-02
DK280085D0 (da) 1985-06-20
NO165496C (no) 1991-02-20
HU192232B (en) 1987-05-28
FI83225C (fi) 1991-06-10
IL75569A (en) 1989-03-31
ES8704967A1 (es) 1987-04-16
IL75569A0 (en) 1985-10-31
AR242036A1 (es) 1993-02-26
PT80663A (en) 1985-07-01
EP0165902B1 (de) 1989-04-19

Similar Documents

Publication Publication Date Title
ES542202A0 (es) Procedimiento para la obtencion de un derivado de nitrometi-leno
ES555049A0 (es) Procedimiento para la obtencion de arilciclopropil-cetonas
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES556895A0 (es) Un procedimiento para la preparacion de l,2,4-triazoles
ES543386A0 (es) Procedimiento para la obtencion de 1-heteroaril-4-aril-pira-zolin-5-onas
ES542207A0 (es) Procedimiento para la obtencion de tetrahidrofuran-2-ilmeti-laminas
ES545967A0 (es) Procedimiento para la obtencion de poliarilensulfuro
ES557112A0 (es) Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide
ES540349A0 (es) Procedimiento para la obtencion de n-sulfonil-n'pirimidil- y -triacinil-ureas
ES550219A0 (es) Procedimiento para la obtencion de aminopolieteres alcoxi- lados
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES549255A0 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
ES528692A0 (es) Procedimiento para la obtencion de un complejo glicoesfingolipidico
ES543820A0 (es) Procedimiento para la obtencion de piperacinil-oxo-quinoli- nas
ES552402A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
ES549266A0 (es) Procedimiento para la obtencion de n-halo-carbonil-fenilhi- drazinas substituidas
ES531516A0 (es) Procedimiento para la obtencion de una (5 )-20-espirox-1-en-3-ona
ES539429A0 (es) Procedimiento para la obtencion de un derivado de sulfonilguanidina
ES546549A0 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
ES542517A0 (es) Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas
ES546192A0 (es) Procedimiento para la obtencion de benzotiazolsulfenamidas
ES552986A0 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas
RO90437A2 (ro) Procedeu de obtinere a unei polizaharide
ES543036A0 (es) Procedimiento para la obtencion de azolilvinileteres
ES555532A0 (es) Procedimiento para la obtencion de benzotiopiranonas

Legal Events

Date Code Title Description
PC1A Transfer granted